Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats New LAL-D

    Launch of LAL-D Knowledge Centre

    A new educational resource on lysosomal acid lipase deficiency is
    now available to epgonline.org users. Content highlights include latest
    disease awareness facts and statistics, important treatment information and
    a video channel comprising expert discussions on topics such
    as diagnostic approach and current prognosis.

  • ,CSU news case studies 2016

    Updates to the Chronic Spontaneous
    Urticaria Knowledge Centre

    Case studies from urticaria experts Professor Christian Vestergaard
    and Professor Torsten Zuberbier have been added to the ‘Case Studies
    section of the Chronic Spontaneous Urticaria Knowledge Centre.
    Additionally, this resource has been updated with information
    on the TARGET My Hives app and refreshed with a whole new look and feel.

  • ,OAC Reversal Whats New 2

    Launch of Oral Anticoagulation Reversal Knowledge Centre

    This new resource provides healthcare professionals with accurate information on the approaches
    to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding,
    or require surgery. View illustrated and referenced sections on management of bleeding, oral
    anticoagulants, symposium highlights, key publications commentary and more. This resource is
    developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with
    content provided by CSL Behring.

    This resource is not intended for healthcare professionals outside Europe.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.


  • ,Cystic Fibrosis Knowledge Centre

    Launch of the Cystic Fibrosis Knowledge Centre

    This new resource has been developed to support healthcare professionals
    in the treatment of patients with cystic fibrosis (CF).
    It contains a host of clinical information including a disease awareness section,
    emerging and supportive therapeutic options and current best practice
    based on recently updated guidelines by the
    European Cystic Fibrosis Society (ECFS).

Latest News

European Commission grants a conditional approval for Zalmoxis as a patient-specific adjunctive treatment in haplo-identical haematopoietic stem-cell transplantation. - MolMed S.p.A.


MolMed S.p.A. announced that the European Commission has granted a Conditional Marketing Authorisation (CMA) for Zalmoxis, the first immunogene therapy, as patient-specific adjunctive treatment in haplo-identical haematopoietic stem-cell ...

EMA validates MAA application for neratinib of HER2-positive early stage breast cancer that has previously been treated with trastuzumab .-Puma Biotechnology Inc.


Puma Biotechnology, Inc. has announced that the Marketing Authorization Application (MAA) for neratinib has been validated by the European Medicines Agency (EMA). Validation of the MAA confirms that the submission is complete and starts the EMA's ...

Pfizer acquires Medivation and with it oncology assets


Pfizer Inc. and Medivation, Inc. have announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, ...

DS Biopharma announces launch of spin out company called Afimmune


DS Biopharma (DS), a privately held drug discovery and development company with industry-leading expertise in lipid science, announces the launch of a spinout company focused solely on fibrotic conditions such as non-alcoholic steatohepatitis (NASH) ...

European Commission approves Cinqaero (reslizumab)as add-on therapy in adult patients with severe eosinophilic asthma. Teva


Teva Pharmaceutical Industries Ltd. announced that the European Commission has granted marketing authorization for Cinqaero (reslizumab) (Cinqair in the US) in the 28 countries of the European Union (EU) in addition to Norway, Liechtenstein and ...

NICE again rejects Nexavar (sorafenib) as a Treatment for liver cancer.-Bayer


The National Institute for Health and Care Excellence (NICE) is re-appraising the drugs which until now were provided under the UK Cancer Drugs Fund (CDF). In 2010 NICE had rejected Nexavar (sorafenib) for the treatment of liver cancer but the drug ...

FDA grants label extension to Trokendi XR (topiramate extended release) in prophylaxis of migraine headache- Supernus Pharmaceuticals


Supernus Pharmaceuticals announced that the FDA has granted tentative approval to the Company’s Supplemental New Drug Application (sNDA) requesting a label expansion for Trokendi XR (topiramate extended release) to include prophylaxis of migraine ...

Recent Updates


Clinical Guidelines

2016 European Guidelines on cardiovascular disease prevention in clinical practice

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

EASL Clinical Practice Guidelines on the management of benign liver tumours

EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones

Medical Journals

Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.

Hypothyroidism and obesity: An intriguing link.

Canakinumab for the treatment of active systemic juvenile idiopathic arthritis.

Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors